Corstasis and U.S. Heart Team Up to Enhance Heart Failure Care
September 25, 2025
Corstasis Therapeutics Inc., a biopharmaceutical company specializing in outpatient treatments for cardiovascular and kidney diseases, has announced a strategic partnership with U.S. Heart and Vascular